Tertiary lymphoid structure topotypes in intrahepatic cholangiocarcinoma: spatial immunity, checkpoint-response associations, and therapeutic reprogramming
This review provides a framework for biomarker development, therapeutic reprogramming, prospective validation, and longitudinal monitoring in ICC and distinguishes candidate circuit-competent, tumor-accessible TLS states from stromally excluded or suppressive-neighborhood states while allowing mixed profiles.